Transaction in Own Shares

/**/

RNS Number : 1909M Science Group PLC 19 December 2025  

 

19 December 2025   Science Group plc (the "Company" or "Science Group")   Transaction in own shares   Science Group plc (AIM:SAG) announces that, on 18 December 2025, it purchased 9,000 of its 1 pence ordinary shares at an average price of 547.5 pence per share. The highest price paid per share was 547.5 pence and the lowest price paid per share was 547.5 pence. The Company purchased these shares through Panmure Liberum Limited.   The number of shares purchased represented 0.02% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.   The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 43,143,642.  Science Group holds 3,042,232 shares in treasury.   The figure of 43,143,642 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.   Schedule of Purchases - Individual Transactions   In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Panmure Liberum Limited on behalf of the Company as part of the buyback programme.  

Number of shares purchased

Transaction price (per share)

Time of transaction

Execution venue

9000

547.5

12:27:33

AIMX

     

- Ends -   For further information:

Science Group plc



Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

  

Panmure Liberum Limited (Nomad and Joint Broker)



Nicholas How, John More

Tel: +44 (0) 20 3100 2000





Peel Hunt LLP (Joint Broker)



Neil Patel, Benjamin Cryer, Kate Bannatyne

Tel : +44(0)20 7418 8900





 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  POSPKFBDOBDDNBD